GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » iNtRON Biotechnology Inc (XKRX:048530) » Definitions » Cyclically Adjusted FCF per Share

iNtRON Biotechnology (XKRX:048530) Cyclically Adjusted FCF per Share : ₩-8.40 (As of Mar. 2025)


View and export this data going back to 2011. Start your Free Trial

What is iNtRON Biotechnology Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

iNtRON Biotechnology's adjusted free cash flow per share for the three months ended in Mar. 2025 was ₩47.836. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ₩-8.40 for the trailing ten years ended in Mar. 2025.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 14.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 27.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of iNtRON Biotechnology was 44.60% per year. The lowest was 4.20% per year. And the median was 19.80% per year.

As of today (2025-06-02), iNtRON Biotechnology's current stock price is ₩4380.00. iNtRON Biotechnology's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was ₩-8.40. iNtRON Biotechnology's Cyclically Adjusted Price-to-FCF of today is .


iNtRON Biotechnology Cyclically Adjusted FCF per Share Historical Data

The historical data trend for iNtRON Biotechnology's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iNtRON Biotechnology Cyclically Adjusted FCF per Share Chart

iNtRON Biotechnology Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -82.65 -34.16 -13.66 -23.37 -21.74

iNtRON Biotechnology Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -10.02 -17.83 -19.02 -21.74 -8.40

Competitive Comparison of iNtRON Biotechnology's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, iNtRON Biotechnology's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


iNtRON Biotechnology's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, iNtRON Biotechnology's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where iNtRON Biotechnology's Cyclically Adjusted Price-to-FCF falls into.


;
;

iNtRON Biotechnology Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, iNtRON Biotechnology's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=47.836/122.5900*122.5900
=47.836

Current CPI (Mar. 2025) = 122.5900.

iNtRON Biotechnology Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -41.354 100.051 -50.670
201509 -52.827 100.111 -64.689
201512 9.388 100.220 11.483
201603 -81.228 100.561 -99.022
201606 -32.541 100.791 -39.579
201609 -41.806 101.461 -50.512
201612 -68.357 101.561 -82.511
201703 -80.838 102.851 -96.353
201706 -17.466 102.611 -20.867
201709 -73.026 103.491 -86.503
201712 -53.896 102.991 -64.152
201803 -86.267 104.101 -101.589
201806 -36.751 104.130 -43.266
201809 -26.017 105.651 -30.188
201812 335.317 104.351 393.927
201903 -6.282 104.491 -7.370
201906 1.556 104.881 1.819
201909 -16.789 105.200 -19.564
201912 3.754 105.121 4.378
202003 -124.468 105.354 -144.831
202006 157.614 105.112 183.822
202009 -34.846 106.198 -40.225
202012 21.963 105.765 25.457
202103 123.960 107.357 141.549
202106 51.827 107.579 59.059
202109 38.031 108.759 42.867
202112 174.428 109.676 194.966
202203 58.951 111.848 64.613
202206 30.363 114.072 32.630
202209 9.728 114.715 10.396
202212 -26.416 115.179 -28.116
202303 16.766 116.507 17.641
202306 37.599 117.182 39.334
202309 -23.331 118.964 -24.042
202312 -222.565 118.837 -229.594
202403 110.619 120.123 112.891
202406 -82.723 120.007 -84.503
202409 -24.699 120.861 -25.052
202412 -35.082 121.135 -35.503
202503 47.836 122.590 47.836

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


iNtRON Biotechnology  (XKRX:048530) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


iNtRON Biotechnology Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of iNtRON Biotechnology's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


iNtRON Biotechnology Business Description

Traded in Other Exchanges
N/A
Address
137, Sagimakgol-ro, Jungwon-gu, Gyeonggi-do, Seongnam-si, KOR
iNtRON Biotechnology Inc is a Korea-based company principally engaged in the biotechnology industry. It develops, manufactures, and commercializes drugs for the treatment of infectious diseases. It is contributing to national health and national prevention through several (molecular) diagnostic products such as swine flu, VRE super bacteria, food poisoning, avian influenza and foot, and mouth disease. In addition, it is also engaged in the operation of a veterinary antibiotic alternative business and new biopharmaceuticals development business.

iNtRON Biotechnology Headlines

No Headlines